Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.

http://www.wikidata.org/entity/Q33944063

about

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol Nutrition and the risk of Alzheimer's disease Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's Disease Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules Sirtuins Link Inflammation and Metabolism Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases Protective effects and mechanisms of sirtuins in the nervous system Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation.Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities Cellular and molecular effects of resveratrol in health and disease Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system Mild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's disease Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicity Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression Superparamagnetic nanoparticle-enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization.A genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression.Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation.AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.Current treatment and recent clinical research in Alzheimer's disease Neuronutrition and Alzheimer's disease Resveratrol differentially modulates inflammatory responses of microglia and astrocytes Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications.Resveratrol: review on therapeutic potential and recent advances in drug delivery.Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease Recommendations for Development of New Standardized Forms of Cocoa Breeds and Cocoa Extract Processing for the Prevention of Alzheimer's Disease: Role of Cocoa in Promotion of Cognitive Resilience and Healthy Brain Aging.Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population.Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ42 by reducing plaque load and motor deficit Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cells A mitocentric view of Alzheimer's disease suggests multi-faceted treatments Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

P2860

Q21089966-52D44314-3622-4434-85F7-F47F452C5FA5 Q22241959-ACF2B469-EB72-4089-B0F4-5607A75519BE Q24617577-71C978D9-6915-400F-BA79-5B96A99997DE Q26738450-EAC57C52-7508-4757-87DE-A6502F17EB00 Q26747742-4F00B93A-DCE3-48F1-997F-2F41187FFECE Q26767141-A35DD2CF-B49F-44BB-A013-43A342FAD201 Q26776093-B21727D3-9DDD-43CF-9113-1FED9170221E Q26825585-FD887CBE-75AF-4622-87B5-BE41B3B42BEB Q26830740-D7F624FD-BCA7-480B-8390-50DA2C63EE6A Q27021700-79CDFE35-A8E7-4703-9B82-283AD6E492A4 Q27309134-9291615F-26AA-48CF-BC09-15936483669A Q27338799-322B6A3E-0949-4EC9-B121-AF783FA25BFF Q28252560-3137D762-4E58-4A5F-B9D5-79D10B49220B Q28259424-7C613DA0-08C1-4046-9FE1-461975EF85DB Q28259585-8695535F-6A3A-493D-82DC-BFC8A65EF429 Q28389419-B32A1FEE-FF82-4FD6-8A59-898095746B10 Q28393932-2E66062E-46BB-4CC2-83CC-97D848B291D5 Q28478772-8C8F89C0-2BC8-4229-A956-14B82FF395DB Q28749173-9BFAECB4-FA76-4E15-9612-5F9D592A0B8C Q30666205-743AA9BF-A14B-4199-8E1F-BEB36B474303 Q31144061-5EFB356C-022C-421A-9414-8AA5AAE32D92 Q33602768-381F05F0-05F9-4850-B85B-D378B7A23915 Q33695751-B67C54D5-14E2-4A76-BE0D-671E82F0D7DD Q33726605-EE07E731-FDAA-4C1D-B326-944048936472 Q34067487-CFA60163-084C-40DC-B9C2-B85E1CC73135 Q34099466-C5E19FFE-75CC-461F-BFB8-52772F4D9EE5 Q34114119-2A02E10D-CA70-4687-9969-DF22892EF94A Q34215149-0ADF01BB-2F5F-4806-AC0A-71B3BD1E873C Q34407220-D3C0C61C-0769-4CC1-968B-D3301733A12F Q34412322-CCBD36C1-6BD6-46EE-801B-4F165D665031 Q34420121-4B89F0C6-928A-4915-99EA-948BE3DB40D1 Q34443537-C30113ED-FC7C-4547-8CCB-7A8A71242347 Q34493731-17BF7F51-2457-45DC-B8C0-1E2D3DC6CD43 Q34495519-9BD55D30-0351-4217-820B-FE5F30564A6D Q34585313-67987F6D-83CE-4E43-96DF-DC18DAE80551 Q34623100-B72EC75F-4272-4DA4-AFD3-61FF0129FA49 Q34631952-29937E7A-74FF-4A20-A94F-CD3DF408BA39 Q34673645-8274E5E3-25ED-44FF-B896-883D71CA3E3B Q34902708-80666B65-3B76-4B49-A993-9A55F84AE8CB Q34994270-07351B6A-6ACA-402C-8548-A6C7EE3B8DE4

P2860

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.

http://www.wikidata.org/entity/Q33944063

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Dietary supplementation with r ...... model of Alzheimer's disease.

@ast

Dietary supplementation with r ...... model of Alzheimer's disease.

@en

type

label

Dietary supplementation with r ...... model of Alzheimer's disease.

@ast

Dietary supplementation with r ...... model of Alzheimer's disease.

@en

prefLabel

Dietary supplementation with r ...... model of Alzheimer's disease.

@ast

Dietary supplementation with r ...... model of Alzheimer's disease.

@en

P1433

Q33944063-C08AAC91-4BA7-40FB-8991-35D647862669

P1476

Q33944063-CD3DE4C9-A6A0-49CF-ACE8-C7973C2B25CD

P2093

Q33944063-1C12F98B-23F5-44E8-BCCE-DD7B3B38460F

Q33944063-2107387B-566F-430F-9A15-46104EE32237

Q33944063-319856F6-3716-4B9F-9604-ED61BF721DFB

Q33944063-525C8757-32D7-46BE-B00B-7EED8AB17C3B

Q33944063-7826BCC9-9C56-4253-B0CE-2B7B3C9CF26A

Q33944063-A42A2E54-5D5A-44DF-8363-65EBEBEB5DEB

P2860

Q33944063-05691ECF-9D26-47B4-BDD6-A8ADF9AA29E3

Q33944063-0F4CC498-4E5C-4940-8B53-B0B19C0C1D07

Q33944063-102B17B4-A4DD-44A4-9EAA-C4C5C8269EB9

Q33944063-1076FDB3-382E-4145-A8FD-56921F267C48

Q33944063-10A9ED00-C099-496A-AA8B-7B59B99B6600

Q33944063-1DE6E168-8F02-425A-B483-07D47042F8B3

Q33944063-202E1B3A-03BF-4F79-87E7-7D5DEB3A7FB6

Q33944063-21E3B4A7-1BE4-464F-8DDB-297166D801F3

Q33944063-31ECC430-ABD5-4D08-9DE9-27C5DDEC3730

Q33944063-370F8271-141F-4270-856A-3E332BB99831

P304

Q33944063-F9FBA60D-CF33-4D52-BFD0-097757C785AE

P31

Q33944063-8B59DF8B-EFBC-4FEF-A57D-919C3F65B53C

P356

Q33944063-88FB4F32-D351-40A2-A01F-1E73FD615AE8

P433

Q33944063-C751ABFF-5C10-4905-ADD1-17F2410249FD

P478

Q33944063-8873D526-AA74-41AF-8906-EFF6917451C2

P577

Q33944063-995C901A-C00A-4FBF-AD7C-5F0BBAA27D40

P5875

Q33944063-04EBA091-7F2E-42C3-9FA4-649B60FDC8DC

P698

Q33944063-4E2CEF04-A74B-48AC-8129-92D8AF3EBB47

P921

Q33944063-0F82CAED-DB25-47EB-8E5F-4FBA97D78994

P932

Q33944063-C670C7B8-F4B6-4ACE-80D8-3F4B66338A59

P356

J.NEUINT.2008.10.008

P1433

Neurochemistry International

P1476

Dietary supplementation with r ...... model of Alzheimer's disease.

@en

P2093

Gary E Gibson

http://www.w3.org/2001/XMLSchema#string

Huan-Lian Chen

http://www.w3.org/2001/XMLSchema#string

Hui Xu

http://www.w3.org/2001/XMLSchema#string

John T Pinto

http://www.w3.org/2001/XMLSchema#string

M Flint Beal

http://www.w3.org/2001/XMLSchema#string

Saravanan S Karuppagounder

http://www.w3.org/2001/XMLSchema#string

P2860

Resveratrol improves health and survival of mice on a high-calorie diet

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis

Mitochondria, oxidants, and aging

Resveratrol protects against global cerebral ischemic injury in gerbils.

Stability of resveratrol over time and in the various stages of grape transformation.

The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration.

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

Inhibition of cancer growth by resveratrol is related to its low bioavailability.

Pharmacologic role of cysteine in ameliorating or exacerbating mineral toxicities.

P304

111-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUINT.2008.10.008

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23554637

http://www.w3.org/2001/XMLSchema#string

P698

19041676

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2892907

http://www.w3.org/2001/XMLSchema#string